Analyses of YBX1 interaction networks reveal potential therapeutic targets for adenocarcinoma, while exploring PABPC1, an YBX1 interaction partner, offers avenues for discovering new drug targets in lung adenocarcinoma (139, 140). The gene discussed is YBX1; the disease is adenocarcinoma.